BPC-157 & TB-500 has shown promise in promoting healing across muscle, tendon, ligament, nerve, and intestinal tissues , making it a popular subject in regenerative medicine and performance research
Most protocols begin with 1-2 injections weekly for 4-8 weeks
thromboxane A2 (TXA2): a substance produced primarily by platelets (via COX-1) that causes vasoconstriction and promotes platelet aggregation
It also appears to influence cell proliferation and modulate inflammation, with different molecular weights, such as LMW and HMW, exhibiting distinct biological activities
The intracellular ATP content was analyzed using ATP kits, and detected by microplate readers [24]
One of the most promising is PT-141, a therapy that works directly on the brains arousal centers rather than only focusing on physical performance